WallStreetZenWallStreetZen

NASDAQ: SVRA
Savara Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SVRA

Based on 5 analysts offering 12 month price targets for Savara Inc

Min Forecast
$2.00-9.5%
Avg Forecast
$5.60+153.39%
Max Forecast
$9.00+307.24%

Should I buy or sell SVRA stock?

Based on 5 analysts offering ratings for Savara Inc.

Buy
Strong Buy
2 analysts 40%
Buy
1 analysts 20%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SVRA's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SVRA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their SVRA stock forecasts and price targets.

SVRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-29
lockedlocked$00.00+00.00%2025-05-28
lockedlocked$00.00+00.00%2025-05-28
lockedlocked$00.00+00.00%2025-05-28
lockedlocked$00.00+00.00%2024-12-19

1 of 1

Forecast return on equity

Is SVRA forecast to generate an efficient return?

Company
5.46%
Industry
140.91%
Market
90.47%
SVRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SVRA forecast to generate an efficient return on assets?

Company
4.26%
Industry
32.45%
SVRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SVRA earnings per share forecast

What is SVRA's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.47
Avg 2 year Forecast
-$0.34
Avg 3 year Forecast
-$0.12

SVRA revenue forecast

What is SVRA's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$40.4M
Avg 2 year Forecast
$84.6M
Avg 3 year Forecast
$122.3M

SVRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SVRA$2.21$5.60+153.39%Buy
LIMN$14.42N/AN/A
ITOS$10.17$16.50+62.24%Buy
FULC$6.85$8.75+27.74%Strong Buy
HUMA$2.37$14.50+511.81%Strong Buy
View Top Biotech Stocks

Savara Stock Forecast FAQ

Is Savara Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: SVRA) stock is to Buy SVRA stock.

Out of 5 analysts, 2 (40%) are recommending SVRA as a Strong Buy, 1 (20%) are recommending SVRA as a Buy, 2 (40%) are recommending SVRA as a Hold, 0 (0%) are recommending SVRA as a Sell, and 0 (0%) are recommending SVRA as a Strong Sell.

If you're new to stock investing, here's how to buy Savara stock.

What is SVRA's earnings growth forecast for 2025-2027?

(NASDAQ: SVRA) Savara's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Savara's earnings in 2025 is -$102,174,000.On average, 4 Wall Street analysts forecast SVRA's earnings for 2025 to be -$80,801,261, with the lowest SVRA earnings forecast at -$84,690,092, and the highest SVRA earnings forecast at -$76,048,246. On average, 3 Wall Street analysts forecast SVRA's earnings for 2026 to be -$58,764,553, with the lowest SVRA earnings forecast at -$77,776,615, and the highest SVRA earnings forecast at -$25,925,538.

In 2027, SVRA is forecast to generate -$20,740,431 in earnings, with the lowest earnings forecast at -$53,579,446 and the highest earnings forecast at $29,382,277.

What is SVRA's revenue growth forecast for 2026-2028?

(NASDAQ: SVRA) Savara's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Savara's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast SVRA's revenue for 2026 to be $6,989,525,126, with the lowest SVRA revenue forecast at $1,686,888,359, and the highest SVRA revenue forecast at $12,292,161,893. On average, 3 Wall Street analysts forecast SVRA's revenue for 2027 to be $14,624,250,481, with the lowest SVRA revenue forecast at $4,761,657,201, and the highest SVRA revenue forecast at $30,141,030,828.

In 2028, SVRA is forecast to generate $21,144,177,690 in revenue, with the lowest revenue forecast at $9,780,841,416 and the highest revenue forecast at $35,400,458,364.

What is SVRA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SVRA) forecast ROA is 4.26%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is SVRA's Price Target?

According to 5 Wall Street analysts that have issued a 1 year SVRA price target, the average SVRA price target is $5.60, with the highest SVRA stock price forecast at $9.00 and the lowest SVRA stock price forecast at $2.00.

On average, Wall Street analysts predict that Savara's share price could reach $5.60 by May 29, 2026. The average Savara stock price prediction forecasts a potential upside of 153.39% from the current SVRA share price of $2.21.

What is SVRA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SVRA) Savara's current Earnings Per Share (EPS) is -$0.48. On average, analysts forecast that SVRA's EPS will be -$0.47 for 2025, with the lowest EPS forecast at -$0.49, and the highest EPS forecast at -$0.44. On average, analysts forecast that SVRA's EPS will be -$0.34 for 2026, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.15. In 2027, SVRA's EPS is forecast to hit -$0.12 (min: -$0.31, max: $0.17).

What is SVRA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SVRA) forecast ROE is 5.46%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.